Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
European Urology
|
September 19, 2022
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer
Ethan S Barnett, Nikolaus Schultz, Konrad H Stopsack, et al.
Cancer Research
|
August 21, 2020
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer
Joseph D Schonhoft, Jimmy L Zhao, Adam Jendrisak, et al.
Science Advances
|
April 5, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
Dan Li, Yu Zhan, Naitao Wang, et al.
British Journal of Cancer
|
November 19, 2023
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
Jimmy L Zhao, Emmanuel S Antonarakis, Heather H Cheng, et al.
The Journal of Biological Chemistry
|
December 4, 2016
Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1
Ha Won Lee, Samia Q Khan, Shehryar Khaliqdina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2021
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide
Landon C Brown, Susan Halabi, Joseph D Schonhoft, et al.
Science (New York, N.Y.)
|
August 18, 2022
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
Joseph M Chan, Samir Zaidi, Jillian R Love, et al.
Immunity
|
November 5, 2013
Anthracyclines induce DNA damage response-mediated protection against severe sepsis
Nuno Figueiredo, Angelo Chora, Helena Raquel, et al.
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies
Samir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies
Samir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
European Urology
|
September 19, 2022
Analysis of BRCA2 Copy Number Loss and Genomic Instability in Circulating Tumor Cells from Patients with Metastatic Castration-resistant Prostate Cancer
Ethan S Barnett, Nikolaus Schultz, Konrad H Stopsack, et al.
Cancer Research
|
August 21, 2020
Morphology-Predicted Large-Scale Transition Number in Circulating Tumor Cells Identifies a Chromosomal Instability Biomarker Associated with Poor Outcome in Castration-Resistant Prostate Cancer
Joseph D Schonhoft, Jimmy L Zhao, Adam Jendrisak, et al.
Science Advances
|
April 5, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
Dan Li, Yu Zhan, Naitao Wang, et al.
British Journal of Cancer
|
November 19, 2023
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)
Jimmy L Zhao, Emmanuel S Antonarakis, Heather H Cheng, et al.
The Journal of Biological Chemistry
|
December 4, 2016
Absence of miR-146a in Podocytes Increases Risk of Diabetic Glomerulopathy via Up-regulation of ErbB4 and Notch-1
Ha Won Lee, Samia Q Khan, Shehryar Khaliqdina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2021
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide
Landon C Brown, Susan Halabi, Joseph D Schonhoft, et al.
Science (New York, N.Y.)
|
August 18, 2022
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
Joseph M Chan, Samir Zaidi, Jillian R Love, et al.
Immunity
|
November 5, 2013
Anthracyclines induce DNA damage response-mediated protection against severe sepsis
Nuno Figueiredo, Angelo Chora, Helena Raquel, et al.
Biorxiv : the Preprint Server for Biology
|
April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies
Samir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 5, 2024
Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies
Samir Zaidi, Jooyoung Park, Joseph M Chan, et al.
Page
of 4